APOTHEEK TOBBACK: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK TOBBACK
Largest movements
- Tangible fixed assets -€36,176
down €36,176 (-49.1%), from €73,645 to €37,469
of which Plant, machinery and equipment: -€36,041
- Receivables within one year +€16,158
up €16,158 (+29.1%), from €55,470 to €71,627
of which Trade receivables: +€15,618
- Cash -€11,719
down €11,719 (-4.6%), from €256,206 to €244,487
mainly Other debts (-€79,844) and Current portion of long-term debt (-€20,056)
- Other debts -€79,844
down €79,844 (-74.0%), from €107,830 to €27,986
- Profit (loss) carried forward +€44,010
up €44,010 (+43.8%), from €100,576 to €144,586
- Trade debts +€37,842
up €37,842 (+83.0%), from €45,615 to €83,457
- Current portion of long-term debt -€20,056
down €20,056 (-66.2%), from €30,278 to €10,222
- Debts after one year -€10,222
down €10,222 (-100%), from €10,222 to €0
- Depreciation -€21,901
down €21,901 (-32.5%), from €67,313 to €45,412
- Gross operating margin -€20,456
down €20,456 (-15.7%), from €130,166 to €109,710
- Financial charges -€5,068
down €5,068 (-44.8%), from €11,323 to €6,255
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €511,522 | €478,492 | -€33,030 | -6.5% |
| Fixed assets | 21/28 | €73,645 | €37,469 | -€36,176 | -49.1% |
| Tangible fixed assets | 22/27 | €73,645 | €37,469 | -€36,176 | -49.1% |
| Plant, machinery and equipment | 23 | €41,762 | €5,721 | -€36,041 | -86.3% |
| Furniture and vehicles | 24 | €4,541 | €3,406 | -€1,135 | -25.0% |
| Other tangible fixed assets | 26 | €27,341 | €28,342 | +€1,001 | +3.7% |
| Current assets | 29/58 | €437,877 | €441,023 | +€3,146 | +0.7% |
| Stocks and contracts in progress | 3 | €120,204 | €118,697 | -€1,506 | -1.3% |
| Stocks | 30/36 | €120,204 | €118,697 | -€1,506 | -1.3% |
| Amounts receivable within one year | 40/41 | €55,470 | €71,627 | +€16,158 | +29.1% |
| Trade receivables | 40 | €53,342 | €68,960 | +€15,618 | +29.3% |
| Other amounts receivable | 41 | €2,127 | €2,667 | +€539 | +25.4% |
| Cash at bank and in hand | 54/58 | €256,206 | €244,487 | -€11,719 | -4.6% |
| Deferred charges and accrued income | 490/1 | €5,998 | €6,211 | +€213 | +3.6% |
| Total equity and liabilities | 10/49 | €511,522 | €478,492 | -€33,030 | -6.5% |
| Equity | 10/15 | €308,017 | €352,027 | +€44,010 | +14.3% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Reserves | 13 | €145,468 | €145,468 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,197 | €6,197 | = | 0.0% |
| Legal reserve | 130 | €6,197 | €6,197 | = | 0.0% |
| Distributable reserves | 133 | €139,271 | €139,271 | = | 0.0% |
| Profit (loss) carried forward | 14 | €100,576 | €144,586 | +€44,010 | +43.8% |
| Amounts payable | 17/49 | €203,505 | €126,465 | -€77,040 | -37.9% |
| Amounts payable after more than one year | 17 | €10,222 | €0 | -€10,222 | -100% |
| Financial debts | 170/4 | €10,222 | €0 | -€10,222 | -100% |
| Amounts payable within one year | 42/48 | €184,790 | €121,665 | -€63,124 | -34.2% |
| Current portion of amounts payable after more than one year | 42 | €30,278 | €10,222 | -€20,056 | -66.2% |
| Trade debts | 44 | €45,615 | €83,457 | +€37,842 | +83.0% |
| Suppliers | 440/4 | €45,615 | €83,457 | +€37,842 | +83.0% |
| Taxes, remuneration and social security | 45 | €1,066 | €0 | -€1,066 | -100% |
| Taxes | 450/3 | €1,066 | €0 | -€1,066 | -100% |
| Other amounts payable | 47/48 | €107,830 | €27,986 | -€79,844 | -74.0% |
| Accrued charges and deferred income | 492/3 | €8,493 | €4,800 | -€3,693 | -43.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €67,313 | €45,412 | -€21,901 | -32.5% |
| Other operating charges | 640/8 | €1,124 | €1,153 | +€29 | +2.6% |
| Gross operating margin | 9900 | €130,166 | €109,710 | -€20,456 | -15.7% |
| Operating profit (loss) | 9901 | €61,729 | €63,145 | +€1,417 | +2.3% |
| Financial income | 75/76B | €1,043 | €1,038 | -€5 | -0.5% |
| Recurring financial income | 75 | €1,043 | €1,038 | -€5 | -0.5% |
| Financial charges | 65/66B | €11,323 | €6,255 | -€5,068 | -44.8% |
| Recurring financial charges | 65 | €11,323 | €6,255 | -€5,068 | -44.8% |
| Profit (loss) for the period before taxes | 9903 | €51,449 | €57,928 | +€6,480 | +12.6% |
| Income taxes | 67/77 | €13,048 | €13,918 | +€870 | +6.7% |
| Profit (loss) for the period | 9904 | €38,400 | €44,010 | +€5,610 | +14.6% |
| Profit (loss) for the period to be appropriated | 9905 | €38,400 | €44,010 | +€5,610 | +14.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.